CROI 2022 的 CCO 独立会议报道*:新 HIV 数据的临床影响 *

2022年2月13-16日; 虚拟的
通过实时网络研讨会、便捷内容摘要和可下载的幻灯片了解有关 HIV 治疗策略、预防和最佳实践的最新数据,并从 CROI 2022 关键研究的伴随评论和播客中获得全球视角。

Share

Program Content

Activities

ClinicalThought:病毒学失败后的多替拉韦
我对病毒学失败患者使用多替拉韦的看法:来自 CROI 2022 的数据
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Activities

幻灯片:CROI 2022
影响我在 CROI 2022 之后的实践的关键 HIV 研究
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 21, 2022

Expires: March 20, 2023

Faculty

cover img faculity

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

cover img faculity

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

cover img faculity

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

Provided by

ProCE Banner

Supporters

由 Gilead Sciences, Inc. 提供的教育补助金 支持。 Janssen Therapeutics,Janssen Products, LP 的事业部 Merck & Co., Inc. ViiV Healthcare

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.